Castle Hook Partners’s Elevance Health ELV Stock Holding History

Castle Hook Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-64,924	Closed	-$18.6M	–	43
2019 Q1	$18.6M	Sell	64,924 -119,394	-65%	-$34.5M	0.94%	22
2018 Q4	$48.4M	Buy	184,318 +114,018	+162%	+$31.4M	6.26%	5
2018 Q3	$19.3M	Sell	70,300 -130,847	-65%	-$34M	0.56%	31
2018 Q2	$47.9M	Buy	+201,147	New	+$46.6M	1.69%	11

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Castle Hook Partners's ELV Position: Q2 2019 in Review

Castle Hook Partners sold out of Elevance Health (ELV) in Q2 2019, closing a stake of 64,924 shares — an estimated $18.6M sold.

Castle Hook Partners first reported a position in ELV in Q2 2018 and held it in 4 quarters. The position peaked at $48.4M in Q4 2018. 1,031 funds tracked by Wall St. Rank hold ELV as of Q2 2019.

Castle Hook Partners reported no remaining Elevance Health position as of Q2 2019 after selling out during the quarter.
Castle Hook Partners sold 64,924 Elevance Health shares in Q2 2019, an estimated $18.6M.
Castle Hook Partners first reported a position in Elevance Health in Q2 2018 and held it in 4 quarters.
Castle Hook Partners's Elevance Health position peaked at $48.4M in Q4 2018.
1,031 funds tracked by Wall St. Rank held Elevance Health as of Q2 2019.

Based on Castle Hook Partners's 13F filing for Q2 2019, filed 14 Aug 2019.